Results
1
-
10
of
86
<
1
2
3
...
8
9
>
Stalmans I; Oddone F; Cordeiro MF; Hommer A; Montesano G; Ribeiro L; Sunaric-M?gevand G; Rossetti L.
Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial.
,
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
[DOI: 10.1007/s00417-016-3299-9]
Yamada H; Yoneda M; Gosho M; Kato T; Zako M.
Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.
,
BMC ophthalmology
[DOI: 10.1186/s12886-016-0202-8]
Rossetti L; Sacchi M; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Vorwerk C; Goldblum D; Fogagnolo P.
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial.
,
BMC ophthalmology
[DOI: 10.1186/1471-2415-15-7]
Crichton AC; Vold S; Williams JM; Hollander DA.
Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension.
,
Advances in therapy
[DOI: 10.1007/s12325-013-0014-7]
Whitson JT; Petroll WM.
Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
,
Advances in therapy
[DOI: 10.1007/s12325-012-0057-1]
Reardon G; Schwartz GF; Kotak S.
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy.
,
BMC ophthalmology
[DOI: 10.1186/1471-2415-10-5]
Paolera MD; Kasahara N; Umbelino CC; Walt JG.
Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use study.
,
BMC ophthalmology
[DOI: 10.1186/1471-2415-8-11]
Frenkel RE; Frenkel M; Toler A.
Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.
,
BMC ophthalmology
[DOI: 10.1186/1471-2415-7-16]
Zeitz O; Matthiessen ET; Reuss J; Wiermann A; Wagenfeld L; Galambos P; Richard G; Klemm M.
Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428].
,
BMC ophthalmology
[DOI: 10.1186/1471-2415-5-6]
Manni G; Centofanti M; Parravano M; Oddone F; Bucci MG.
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.
,
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
[DOI: 10.1007/s00417-004-0866-2]
<
1
2
3
...
8
9
>